Found: 1
Select item for more details and to access through your institution.
In vitro evaluation of global coagulation potentials in the co‐presence of plasma‐derived factors Viia/X products (Byclot<sup>®</sup>) and emicizumab in patients with haemophilia A and inhibitors and acquired haemophilia A: A pilot study.
- Published in:
- Haemophilia, 2022, v. 28, n. 5, p. e149, doi. 10.1111/hae.14650
- By:
- Publication type:
- Article